Abstract:Objective: To evaluate the risk of hysterectomy at the time of myomectomy and the associated 30-day postoperative morbidity. Design: Cohort study. Patients: Patients who underwent myomectomies identified from the American College of Surgeons' National Surgical Quality Improvement Program from 2010 to 2021. Intervention: Unplanned hysterectomy at the time of a myomectomy procedure. Main outcome measures: The Current Procedural Terminology codes were used to identify myomectomies performed with or without concurrent hysterectomy. Preoperative characteristics and morbidity outcomes were obtained. The univariate analysis was performed using the chi-square and Fisher exact tests, as appropriate. Multivariate logistic regression reported risk factors for individuals who underwent hysterectomy at the time of myomectomy. P values of <.05 were considered statistically significant. Results: A total of 13,213 individuals underwent myomectomy, and 399 (3.0%) had a hysterectomy performed during myomectomy. Concurrent hysterectomy was most frequently performed with the laparoscopic approach (7.1%), followed by the abdominal (3.2%) and hysteroscopic (1.9%) approaches. Age ≥43 years, obesity class II and higher, American Society of Anesthesiologists (ASA) class greater than II, tobacco use, longer operative time (>85 minutes), and laparoscopic approach were associated with a significantly increased risk of hysterectomy. When adjusting for age, body mass index, race, ASA class, case type, surgical approach, operative time, preoperative transfusion, preoperative hematocrit, and high fibroid burden, an increased odds of hysterectomy was noted for white race, longer operative time, ASA class III or higher, obesity, laparoscopic approach, and low fibroid burden. Patients who underwent concurrent hysterectomy had a longer median length of hospital stay (2 vs. 1 day), longer median operative time (161 vs. 126 minutes), increased intraoperative/postoperative blood transfusions (14.5% vs. 9.0%), and higher rates of organ/space surgical site infections (1.5% vs. 0.5%) and return to surgery (2.0% vs. 0.7%) than those who did not (P<.05). The risk of a major complication within 30 days of myomectomy increased in patients who underwent concurrent hysterectomy after adjusting for relevant confounders (adjusted odds ratio, 2.4; 95% confidence interval, 1.8-3.2). Conclusion: The risk of hysterectomy during a myomectomy is higher than previously reported. The patient age of ≥43 years, obesity, white race, ASA class III or higher, longer operative time, and laparoscopic approach were associated with higher odds of hysterectomy. Identification of patients with these risk factors can aid in patient counseling and surgical planning, which may help reduce the unexpectedly high rates of hysterectomy at planned myomectomy.

Risk of overactive bladder after hysterectomy for uterine fibroids

The Risk of Stress Urinary Incontinence After Hysterectomy for Uterine Fibroids

Hysterectomy is not associated with increased risk of urinary incontinence-a northern Finland birth cohort 1966 study

The risk in the patients with adenomyosis after supracervical hysterectomy

Increased risk of atrial fibrillation in patients with uterine fibroids: a nationwide population-based study

Risk of pelvic organ prolapse after hysterectomy for benign conditions: A nationwide cohort study

Hysterectomy and risk of ovarian cancer: a systematic review and meta-analysis

The influence of uterine surgery on the ovarian function of women during the reproduc-tive period

Hysterectomy, oophorectomy and risk of non-Hodgkin's lymphoma

Urinary Dysfunction after Hysterectomy: Incidence, Risk Factors and Management

Positive association of female overactive bladder symptoms and estrogen deprivation: A nationwide population-based cohort study in Taiwan

Comparing the effect of laparoscopic supracervical and total hysterectomy for uterine fibroids on ovarian reserve by assessing serum anti-mullerian hormone levels: a prospective cohort study

Risk of hysterectomy at the time of myomectomy: an underestimated surgical risk

Association between breast diseases and symptomatic uterine fibroids by using South Korean National Health Insurance database

Hysterectomy and risk of osteoarthritis in women: a nationwide nested case-control study

The Risk of Primary Uterine and Cervical Cancer After Hysteropexy

[Analysis of risk factors for long-term overactive bladder after radical prostatectomy].

High Recurrence Rate of Uterine Fibroids on Transvaginal Ultrasound after Abdominal Myomectomy in Japanese Women

Hysterectomy, Oophorectomy, and Risk of Thyroid Cancer

Association of Pelvic Floor Function with Postoperative Urinary Incontinence in Cervical Cancer Patients after the Radical Hysterectomy

Examining the association of hysterectomy with and without oophorectomy on cardiovascular disease and all‐cause, cardiovascular or cancer mortality: A systematic review and meta‐analysis